Sign in
Join
Log In
Profile
Log Out
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Search
Type here...
Search
Home
Trending
Analysis
LENS Index
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Search
Type here...
Search
Home
Trending
Analysis
LENS Index
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
X
Youtube
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
X
Youtube
Home
About Us
Trending
Analysis
LENS Index
Research Reports
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Home
About Us
Trending
Analysis
LENS Index
Research Reports
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Healthcare
Technology & AI
M&A
Miscellaneous
Consumer & Retail
Healthcare
Energy
Moderna Cancer Vaccine: Why Shares Crashed 18%
Healthcare
Ishan M.
-
October 23, 2026
Imagine a company reporting encouraging cancer treatment results, only to watch its stock plunge nearly 18% in a single day. That is what happened...
Moderna Cancer Vaccine Faces Its Bigger Test
Healthcare
Ishan Majumdar
-
August 20, 2026
Moderna (NASDAQ:MRNA) just experienced the kind of stock move that biotech investors rarely see. The Moderna cancer vaccine result quickly became the center of...
P&G Thorne Acquisition: $3.8 Billion Deal &Wellness Synergies
Healthcare
Ishan Majumdar
-
August 11, 2026
Procter & Gamble (NYSE:PG) has moved deeper into health and wellness with its $3.8 billion all-cash agreement to acquire...
Kenvue Tylenol Lawsuits Cloud $48.7 Billion Deal
Healthcare
Ishan Majumdar
-
July 14, 2026
Kenvue (NYSE:KVUE) woke up on July 13 with an old legal threat suddenly alive again. A federal appeals court...
Moderna’s Flu Shot Won Over FDA Advisers—But Can It Win Back America?
Healthcare
Ishan Majumdar
-
June 19, 2026
Moderna (NASDAQ:MRNA) just landed a regulatory moment that people will argue about far beyond Wall Street. An FDA advisory...
Novo Nordisk Earnings Pre-Mortem: The Beat May Not Be Enough!
Healthcare
Ishan M.
-
May 5, 2026
Novo Nordisk reports first-quarter 2026 earnings on May 6, and the market is walking into the print with unusually...
This Telehealth Stock Rally By RFK Jr. Looks Like Policy; It’s Actually A Margin SHIFT
Healthcare
Ishan Majumdar
-
April 17, 2026
Hims & Hers Health (NYSE:HIMS) did not report a surprise quarter, launch a blockbuster product, or raise guidance when...
Eli Lilly’s Foundayo & The GLP-1 Pivot From Innovation to Access Control!
Healthcare
Ishan Majumdar
-
April 10, 2026
Most coverage of Eli Lilly’s(NYSE:LLY) Foundayo launch has treated it like the next round in the company’s fight with...
Load more
Moderna Cancer Vaccine: Why Shares Crashed 18%
Healthcare
Ishan M.
-
October 23, 2026
Imagine a company reporting encouraging cancer treatment results, only to watch its stock plunge nearly 18% in a single...
Moderna Cancer Vaccine Faces Its Bigger Test
Healthcare
Ishan Majumdar
-
August 20, 2026
Moderna (NASDAQ:MRNA) just experienced the kind of stock move that biotech investors rarely see. The Moderna cancer vaccine result...
P&G Thorne Acquisition: $3.8 Billion Deal &Wellness Synergies
Healthcare
Ishan Majumdar
-
August 11, 2026
Procter & Gamble (NYSE:PG) has moved deeper into health and wellness with its $3.8 billion all-cash agreement to acquire...
Kenvue Tylenol Lawsuits Cloud $48.7 Billion Deal
Healthcare
Ishan Majumdar
-
July 14, 2026
Kenvue (NYSE:KVUE) woke up on July 13 with an old legal threat suddenly alive again. A federal appeals court...
Moderna’s Flu Shot Won Over FDA Advisers—But Can It Win Back America?
Healthcare
Ishan Majumdar
-
June 19, 2026
Moderna (NASDAQ:MRNA) just landed a regulatory moment that people will argue about far beyond Wall Street. An FDA advisory...
Novo Nordisk Earnings Pre-Mortem: The Beat May Not Be Enough!
Healthcare
Ishan M.
-
May 5, 2026
Novo Nordisk reports first-quarter 2026 earnings on May 6, and the market is walking into the print with unusually...
This Telehealth Stock Rally By RFK Jr. Looks Like Policy; It’s Actually A Margin SHIFT
Healthcare
Ishan Majumdar
-
April 17, 2026
Hims & Hers Health (NYSE:HIMS) did not report a surprise quarter, launch a blockbuster product, or raise guidance when...
Eli Lilly’s Foundayo & The GLP-1 Pivot From Innovation to Access Control!
Healthcare
Ishan Majumdar
-
April 10, 2026
Most coverage of Eli Lilly’s(NYSE:LLY) Foundayo launch has treated it like the next round in the company’s fight with...
This Biotech Stock Already Has A Blockbuster; So Why Is It ACQUIRING Another Rare Disease Asset?
Healthcare
Ishan M.
-
April 6, 2026
There are biotech stories that look obvious, and then there are biotech stories that quietly change shape right in...
This Medical Device Stock Just Got CRUSHED On One Hidden Number; Did Wall Street Misread It?
Healthcare
Ishan Majumdar
-
March 31, 2026
Boston Scientific (NYSE:BSX) spent the weekend putting forward what looked, at first glance, like a clinically solid case for...
A First-In-Class Biotech Is Still Trading Below Its Strategic Value Today
Healthcare
Ishan Majumdar
-
March 27, 2026
A mid-cap biotech with the first approved therapy in a large, long-underfunded liver disease category is not supposed to...
Is Align A Classic Activist Win, Or A HARDER Consumer Story?
Healthcare
Ishan Majumdar
-
March 19, 2026
Align Technology (NASDAQ:ALGN) has become a useful test case for a very modern market question. What happens when Wall...
Load more